Clinical Trial Update: Single-shot Adductor Canal Block With Levobupivacaine and Dexmedetomidine in Total Knee Arthroplasty [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluated a single-shot adductor canal block using levobupivacaine with dexmedetomidine in total knee arthroplasty, and the study has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee
• Total Knee Arthroplasty

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• levobupivacaine (levobupivacaine)

Snippet

Sponsor: Assiut University | Conditions: Adductor Canal Block, Levobupivacaine | Phase 2, Phase 3 | Status: COMPLETED